Real-time enrollment status for this myasthenia gravis, generalized clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 2:12 PM UTC
| NCT Number | NCT07596901 |
| Recruiting Status | Recruiting |
| Condition | Myasthenia Gravis, Generalized |
| Phase | PHASE1 |
| Target Enrollment | 81 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Aurinia Pharmaceuticals Inc. |
| Last Updated on CT.gov | August 3, 2026 (3 weeks ago) |
As of August 29, 2026: Clinical trial NCT07596901 is currently recruiting participants. This phase1 study for myasthenia gravis, generalized is actively seeking new participants at 11 locations across the United States. The study is sponsored by Aurinia Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07596901 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07596901 was last updated 3 weeks ago (August 3, 2026). HelloStudys verifies this status automatically.